Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2024-01-09T12:38:25

ABIRASTERON 250 Abiraterone Acetate lp (250mg) Abiraterone acetate is a medication used in the treatment of prostate cancer. It belongs to a class of drugs known as androgen biosynthesis inhibitors and is commonly used in combination with other medications for the management of advanced prostate cancer. Here are some key points about abiraterone acetate: Indications: ABIRASTERON 250 is primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). It is often prescribed in combination with prednisone or prednisolone. Mechanism of Action: ABIRASTERON 250 inhibits the activity of an enzyme called CYP17, which is involved in the production of androgens (male hormones) in the adrenal glands and prostate cancer cells. By blocking androgen production, abiraterone helps slow down the progression of prostate cancer. Dosage: The typical dosage of abiraterone acetate is often 1, 000 mg (four tablets of 250 mg each) taken orally once daily. It is usually prescribed with prednisone or prednisolone. Administration: Abiraterone acetate is taken orally on an empty stomach, usually at least one hour before or two hours after meals. Monitoring: Regular monitoring of prostate-specific antigen (PSA) levels and other relevant parameters is important during treatment to assess the patient's response and manage potential side effects. Side Effects: Common side effects of abiraterone acetate may include fatigue, hypertension (high blood pressure), fluid retention, joint swelling or discomfort, and liver function abnormalities. It is important to report any severe or persistent side effects to the healthcare provider. Pregnancy Considerations: Abiraterone acetate is not indicated for use in women and should not be used during pregnancy. It can harm the developing fetus. Drug Interactions: Abiraterone acetate may interact with other medications, and it is important to inform the healthcare provider about all medications, including over-the-counter drugs and supplements, being taken. Duration of Treatment: The duration of abiraterone acetate treatment can vary based on the individual patient's response and the progression of the disease. It is crucial for individuals to take abiraterone acetate exactly as prescribed by their healthcare provider. Any concerns or side effects should be promptly discussed with the treating physician. This information provides a general overview, and specific details about the use of abiraterone acetate should be discussed with a healthcare professional. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/abirasteron-250-133650

ABIRASTERON 250 Abiraterone Acetate lp (250mg) Abiraterone acetate is a medication used in the treatment of prostate cancer. It belongs to a class of drugs known as androgen biosynthesis inhibitors and is commonly used in combination with other medications for the management of advanced prostate cancer. Here are some key points about abiraterone acetate: Indications: ABIRASTERON 250 is primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). It is often prescribed in combination with prednisone or prednisolone. Mechanism of Action: ABIRASTERON 250 inhibits the activity of an enzyme called CYP17, which is involved in the production of androgens (male hormones) in the adrenal glands and prostate cancer cells. By blocking androgen production, abiraterone helps slow down the progression of prostate cancer. Dosage: The typical dosage of abiraterone acetate is often 1, 000 mg (four tablets of 250 mg each) taken orally once daily. It is usually prescribed with prednisone or prednisolone. Administration: Abiraterone acetate is taken orally on an empty stomach, usually at least one hour before or two hours after meals. Monitoring: Regular monitoring of prostate-specific antigen (PSA) levels and other relevant parameters is important during treatment to assess the patient's response and manage potential side effects. Side Effects: Common side effects of abiraterone acetate may include fatigue, hypertension (high blood pressure), fluid retention, joint swelling or discomfort, and liver function abnormalities. It is important to report any severe or persistent side effects to the healthcare provider. Pregnancy Considerations: Abiraterone acetate is not indicated for use in women and should not be used during pregnancy. It can harm the developing fetus. Drug Interactions: Abiraterone acetate may interact with other medications, and it is important to inform the healthcare provider about all medications, including over-the-counter drugs and supplements, being taken. Duration of Treatment: The duration of abiraterone acetate treatment can vary based on the individual patient's response and the progression of the disease. It is crucial for individuals to take abiraterone acetate exactly as prescribed by their healthcare provider. Any concerns or side effects should be promptly discussed with the treating physician. This information provides a general overview, and specific details about the use of abiraterone acetate should be discussed with a healthcare professional. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/abirasteron-250-133650

  • 2024-01-09T12:38:25

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us